MEDAVAIL HOLDINGS INC's ticker is MDVL and the CUSIP is 58406B103. A total of 1 filers reported holding MEDAVAIL HOLDINGS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 8.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $5,269 | +1136.9% | 21,496 | +1344.6% | 0.00% | – |
| Q1 2023 | $426 | -4.5% | 1,488 | +0.2% | 0.00% | – |
| Q4 2022 | $446 | -55.4% | 1,485 | +0.3% | 0.00% | – |
| Q3 2022 | $1,000 | -50.0% | 1,481 | +1.3% | 0.00% | – |
| Q2 2022 | $2,000 | -92.9% | 1,462 | -95.1% | 0.00% | – |
| Q1 2022 | $28,000 | +133.3% | 29,605 | +259.4% | 0.00% | – |
| Q4 2021 | $12,000 | -87.0% | 8,238 | -73.7% | 0.00% | – |
| Q3 2021 | $92,000 | +475.0% | 31,343 | +2281.7% | 0.00% | – |
| Q2 2021 | $16,000 | -11.1% | 1,316 | -0.3% | 0.00% | – |
| Q1 2021 | $18,000 | – | 1,320 | +32900.0% | 0.00% | – |
| Q4 2020 | $0 | – | 4 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG-WTT Global Life Science Capital Partners GP Ltd | 15,029,480 | $22,995,000 | 81.12% |
| Ally Bridge Group (NY) LLC | 5,894,897 | $9,019,000 | 8.22% |
| Redmile Group, LLC | 25,192,751 | $38,545,000 | 1.47% |
| CIGNA INVESTMENTS INC /NEW | 2,389,478 | $3,656,000 | 0.73% |
| Alyeska Investment Group, L.P. | 7,529,411 | $11,520,000 | 0.13% |
| PURA VIDA INVESTMENTS, LLC | 714,120 | $1,093,000 | 0.06% |
| Alpha Paradigm Partners, LLC | 57,539 | $88,000,000 | 0.04% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 836,626 | $1,280,000 | 0.03% |
| Belvedere Trading LLC | 242,100 | $332,000 | 0.01% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,000,000 | $1,530,000 | 0.00% |